Vault-13

SHL TELEMEDICINE LTD SHLT

SPONSORED ADS · ADR · CUSIP 78423T200

2 institutional holders
714,573714.6k shares reported held*
$8.0mreported value*

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $11.14.

Biggest buyers

Biggest sellers

None

Major shareholders (over 5%)

Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.

HolderStakeChangeShares Last filed
Value Base Ltd. 13D · may seek influence filed 2025-12-05
Stated purposeItem 4 of the Schedule 13D is amended to add the following: The information set forth in Item 3 is incorporated herein by reference. Full filing
15.2% 5.6m 2025-12-05
Danbar Finance Ltd. 13D · may seek influence filed 2025-12-15
Stated purposeThis item is not being amended by this Schedule 13D/A. Full filing
9.9% 3.7m 2025-12-15

Holders, Q2 2023

#ManagerLocationShares Value% of their portfolioChangeShares change
1 SPHERA FUNDS MANAGEMENT LTD. 1.71% of their portfolio TEL AVIV, L3 714,573714.6k $8.0m $8.0m 1.71% New
2 CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio BIRMINGHAM, AL 00 $0 $0 0.00% New